Skip Navigation

Biometrika 2006 93(4):895-910; doi:10.1093/biomet/93.4.895
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by Berry, K.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 Biometrika Trust

Semiparametric estimation of marginal mark distribution

Yijian Huang1 and Kristin Berry2

1 Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, U.S.A. yhuang5{at}emory.edu, 2 Department of Biostatistics, University of Washington, Seattle, Washington 98195, U.S.A. kberry{at}u.washington.edu


   Abstract

In many applications, the outcome of interest is a mark such that its observation is contingent upon occurrence of an event. With incomplete follow-up data, the marginal mark distribution is, however, nonparametrically nowhere identifiable in many practical situations. To address this problem, we suggest a semiparametric model that postulates a normal copula for the association between the mark and survival time, but leaves the marginals unspecified. We show identifiability of the marginal mark distribution under this model, and propose an inference procedure. The estimated marginal distribution function is consistent and asymptotically normal, and it provides a basis for estimating summaries of the mark. Furthermore, we propose graphical model-checking methods and Kolmogorov–Smirnov-type goodness-of-fit tests. Simulation studies demonstrate that the inference procedure performs well in practical settings. The method is applied to the estimation of lifetime medical cost in a lung cancer trial.

Key Words: Copula; Goodness-of-fit test; Identifiability; Induced dependent censoring; Kolmogorov–Smirnov statistic; Linear transformation model; Marked point process; Medical cost; Normal copula; Quality-adjusted survival time.


Received July 2004. Revised March 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.